latest news releases from the newsroom
IBM Showcases SightLogix At Pipeline Security Forum 2007
PRINCETON, N.J., Nov. 5, 2007 (PRIME NEWSWIRE) -- IBM showcased SightLogix' automated outdoor surveillance solution at the recently concluded 2007 International Pipeline Security Forum in Ottawa. This annual, invitation-only forum was hosted by the DHS and the Energy Infrastructure Protection Division of Natural Resources Canada.
State Bank Corp.
State Bank Corp. Reports Earnings
LAKE HAVASU CITY, Ariz., Nov. 5, 2007 (PRIME NEWSWIRE) -- State Bank Corp. (OTCBB:SBAZ), the holding company for Mohave State Bank, announced third quarter 2007 net income of $1.463 million, a 6.9% increase from the $1.369 million reported for the third quarter of 2006. Diluted earnings per share for the third quarter of 2007 were $0.37 compared to $0.35 for the third quarter of 2006. Year-to-date, net income was $4.221 million, up 3.15% from the $4.092 million for the 2006 nine month period; diluted earnings per share were $1.08 compared with $1.05 for the same period, an increase of 2.9% year-over-year. Loan growth continues to enhance the bank's profitability, growing $20.5 million, or 8.74% over the third quarter of 2006.
Houston Wire & Cable Company
Houston Wire & Cable Company Appoints New Chairman of the Board
HOUSTON, Nov. 5, 2007 (PRIME NEWSWIRE) -- Houston Wire & Cable Company (Nasdaq:HWCC), a leading distributor of specialty wire and cable throughout the United States, announced today the election of Scott L. Thompson as non-executive Chairman of its Board of Directors. He will succeed Peter M. Gotsch, who resigned as Chairman on November 1, 2007. Mr. Gotsch, a member of Code Hennessy & Simmons, LLC (CHS) elected to step down as Chairman following the distribution of HWCC shares formerly held by a Code Hennessy & Simmons fund to fund investors.
Generex Biotechnology Corp.
Generex Biotechnology to Present At The Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City Today
WORCESTER, Mass., Nov. 5, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced that Anna Gluskin, its Chairman and Chief Executive Officer, will present at The Rodman & Renshaw Acumen BioFin 9th Annual Healthcare Conference in New York City today at 3:00 p.m. Eastern Time. The conference will be held at The New York Palace Hotel, New York City. The Company's audio portion and slides of its presentation will also be webcast live and archived for future reference at http://www.wsw.com/webcast/rrshq12/gnbt.
EDAP TMS SA
EDAP TMS S.A. Closes $20 Million Placement to Fully Fund Its U.S. Clinical Studies
LYON, France, Nov. 5, 2007 (PRIME NEWSWIRE) -- EDAP TMS S.A. (Nasdaq:EDAP), the global leader in High Intensity Focused Ultrasound treatment of prostate cancer, announces that it has closed its capital raise with selected U.S. based qualified institutional buyers, pursuant to which the investors purchased US $20 million in Unsecured Convertible Debentures, convertible into EDAP's ordinary shares, to be delivered in the form of American Depository Receipts ("ADRs"). The Company expects this investment to fully fund EDAP's ongoing Phase II/III clinical studies of Ablatherm-HIFU at selected leading cancer treatment centers across the U.S. Eligibility criteria and center information can be found online at www.clinicaltrials.gov or at participating centers.